were used as markers for the membrane and cytoplasmic fractions of the cell, respectively. The negative staining of Cadherin in the cytoplasmic fraction and the negative staining of RPS20 in the membrane fraction confirmed the purity of each fraction.
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Nitrocellulose phospholipid binding assays. We used PIP-and Sphingo-strips, which are nitrocellulose membranes spotted with 100 pmol of different lipids per spot. PIP-and Sphingo-strips were blocked for 1 h with 3% fatty acid-free bovine serum albumin in Tris buffer saline (Gentic, Abelbio, Korea) supplemented with 0.1% tween 20 (TBST).
Human ASBT protein at a concentration of 0.5 µg/mL was incubated for 2 h at 4 ºC with the nitrocellulose membrane in TBST. After repeated washing, lipid-bound ASBT was detected using anti-ASBT (C-terminal), followed by incubation with HRP-coupled secondary antibody. Membranes were developed using an enhanced chemiluminescence To check the interactions, cells were treated with biotin-labeled LHe-tetraD and the whole lysates or fractions were collected following the procedures explained earlier.
At first, the biotin pull-down assay was optimized using the streptavidin trail kit. Among four different Dynabeads ® applied here, maximum biotin was pulled down by using MyOne TM streaptavidin C1 beads from the lysate of LHe-tetraD-biotin-treated cells.
Next, streptavidin C1 beads were added to the whole-cell lysates (total 2 mg protein) or to the membrane (total 2 mg protein) and cytoplasmic (total 1.2 mg protein) fractions and incubated overnight at 4 ºC with gentle rocking. Streptavidin beads were washed with IP buffer at least three times, heated in deionized water at 70 ºC for 3 min, and subjected to SDS-PAGE analysis. The membranes were separately blotted with ASBT (C-terminal)
antibodies against 12% gel and biotin antibodies against 15% gel.
Proximity ligation assay (PLA).
For PLA, cells were treated as indicated, immediately fixed in 4% PFA for 20 min, and thereafter subjected to in situ PLA using a Duolink
Detection kit (Olink Bioscience, Uppsala, Sweden) following the manufacturer's instructions. Briefly, slides were blocked, incubated with anti-ASBT (N-terminal) and anti-biotin, and thereafter incubated with PLA probes, which are secondary antibodies (anti-rabbit and anti-mouse, respectively) conjugated to unique oligonucleotides. Ligation of the oligonucleotides was followed by an amplification step. The products were detected by using a complementary fluorescently labeled probe. Slides were mounted using mounting media and evaluated using the confocal microscope. An ASBT antibody immunogenic to N-terminal region of ASBT was chosen, considering the fact that PLA only allowed the detection of two interacting molecules when it remained in close proximity of less than 40 nm. The use of antibodies that are immunogenic to N-terminal rather than C-terminal region of ASBT minimized the effects associated with the distance between LHe-tetraD and antibody binding site in this case.
